Il tuo browser è obsoleto

Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.

×

Skip to main content

Professionisti del settore sanitario

Bioresorbable Ear Packing and Patching Products

for Middle Ear Surgery and Other Otologic Procedures

  • bioresorbable-ear-packing-and-patching-products

MeroGel Injectable Ear Packing

MeroGel Injectable is a bioresorbable ear packing that helps aid postoperative wound healing, prevent adhesions, and control minimal bleeding. This ear packing is used in middle ear surgery and otologic procedures such as canalplasty, myringoplasty, tympanoplasty, and stapes and mastoid surgery.

MeroGel Injectable Bioresorbable Ear Packing

Convenient Delivery Access

MeroGel® Injectable is a transparent, viscoelastic, bioresorbable gel composed of cross-linked polymers of hyaluronic acid. It's administered with a flexible catheter for easier access.

After middle ear surgery and other otologic procedures, MeroGel Injectable ear packing is intended to:

  • Separate and prevent adhesions between mucosal surfaces
  • Help control minimal bleeding following surgery
  • Act as an adjunct to aid in the natural healing process

Hyaluronic Acid and Middle Ear Surgery

In middle ear surgery, biocompatible1-7 hyaluronic acid has been shown to improve the natural healing of the mastoid cavity following tympanoplasty and help reduce fibrous scarring.1-4

Additional Ear Packing and Patching Products

See the ENT Product Catalog for all ear packing products, including traditional ear packing and wicks.

HYAFF® is a registered trademark of Anika Therapeutics SRL.

 

References

1

Sayin I, Kaya KH, Ekizoğlu O, Erdim I. A prospective controlled trial comparing spontaneous closure and EpiFilm patching in traumatic tympanic membrane perforations. Eur Arch Otorhinolaryngol. 2012. Epub: 2013 January 5. doi: 10.1007/s00405-012-2331-x.

2

Saliba I, Knapik M, Froehlich P, Abela A. Advantages of hyaluronic acid fat graft myringoplasty over fat graft myringoplasty. Arch Otolaryngol Head Neck Surg. 2012; 138(10):950-955.

3

Laurent C, Hellstrom S, Stenfors L. Hyaluronic acid reduces connective tissue formation in middle ears filled with absorbable gelatin sponge: an experimental study. Am J Otolaryngol.1986; 7:181-186.

4

Martini A, Morra B. Use of a hyaluronan-based biomembrane in the treatment of chronic cholesteatomatous otitis media. Am J Otology. 2000; 21:468-473.

5

Pirnazar P, et al. Bacteriostatic effects of hyaluronic acid. J Periodontol. 1999; 70:370-374.

6

Longaker MT, et al. Studies in fetal wound healing. A prolonged presence of hyaluronic acid characterized wound fluid. Annals of Surgery. 1991; 213:292-296.

7

Grainger DA, et al. The use of hyaluronic acid polymers to reduce postoperative adhesions. J Gynecol Surg. 1991; 7:97-101.

Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.